Deals Bayer and investment firm Versant Ventures have jointly provided $225m in series A funding for a regenerative medicine startup called BlueRock Therapeutics. Symphony emerged two years ago with $66m from 14 banks and followed that funding up with a $100m Google-backed round last year. Now the company, which offers a secure messaging platform for … Continue reading "19 December 2016 – $225m for BlueRock Therapeutics, Microsoft Ventures Invests from its AI Fund and Much More"